EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Erinacine C Attenuates Alzheimer’s-like Pathology: A Study in APP/PS1 Mice and PC12 Cells

Li-Yu Wang, Shu-Lan Yeh, Shih-Tien Hsu, Shu-Ming Huang, Chi-Fai Chau iD, Cheng-Hung Chuang iD

Molecules · 2026

DOI: 10.3390/molecules31183154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Li-Yu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Hungkuang University, Taichung 43302, Taiwan. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroprotective Agents, Presenilin-1, Amyloid beta-Protein Precursor. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Science and Technology Council (NSTC), Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta (Aβ) deposition and cognitive decline. Clinical evidence indicates that Hericium erinaceus whole fruiting body powder offers limited therapeutic efficacy, which is suggested to be constrained by whole-food matrix interference and uncertainties in central nervous system (CNS) exposure. Therefore, we hypothesized that erinacine C (EC)—a purified active component from Hericium erinaceus mycelia—could resolve these limitations and potentially exhibit favorable neuroprotective effects owing to its low molecular weight and lipophilicity. In this study, we investigated the neuroprotective potential and associated signaling alterations of EC using APP/PS1 transgenic mice and Aβ25-35-induced PC12 cells. In vivo, oral administration of EC alleviated deficits in activities of daily living, as evidenced by improvements in nesting and burrowing behaviors, along with enhanced short-term spatial memory in the Y-maze test. EC treatment was associated with a reduction in hippocampal Aβ plaque accumulation, suppression of glial activation (GFAP and IBA1), and decreased IL-6 levels in both serum and hippocampal tissues. In vitro, EC intervention counteracted Aβ25-35-induced cytotoxicity in PC12 cells. Analysis of signaling markers revealed that EC treatment was accompanied by a restoration of p-Akt/Akt levels and a suppression of p-GSK3β (Tyr216) activation. Consequently, EC treatment was correlated with reduced tau hyperphosphorylation, the up-regulation of the anti-apoptotic protein Bcl-2, and the down-regulation of pro-apoptotic markers including Bax and cleaved-caspase-3, thereby lowering the total apoptotic rate. Taken together, these findings suggest that EC may mitigate cognitive impairment and neurodegeneration in parallel with alterations in the Akt/GSK3β/tau/caspase-3 signaling response, thereby representing a potentially promising therapeutic candidate for the intervention of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroprotective AgentsPresenilin-1Amyloid beta-Protein PrecursorAnimalsPC12 CellsRatsMiceMice, TransgenicDisease Models, AnimalApoptosisSignal TransductionAmyloid beta-PeptidesHippocampusHericiumProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

APP/PS1 miceAkt/GSK3β signalingAlzheimer’s diseaseHericium erinaceusapoptosiserinacine Cneuroinflammationtau phosphorylation

Substanzen

Neuroprotective AgentsPresenilin-1Amyloid beta-Protein PrecursorAmyloid beta-PeptidesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Nutrition, Hungkuang University, Taichung 43302, Taiwan.
  • Department of Food Science and Biotechnology, National Chung Hsing University, Taichung 40227, Taiwan.
  • Department of Nutrition, Chung Shan Medical University, Taichung 40203, Taiwan.
  • Department of Obstetrics and Gynecology and Women's Health, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
  • Department of Nutrition, Nantou Hospital of Ministry of Health and Welfare, Nantou 54062, Taiwan.

ORCID-Profile: Chi-Fai Chau, Cheng-Hung Chuang

Förderung

  • National Science and Technology Council
  • National Science and Technology Council (NSTC), Taiwan

Zitieren

APA

Wang, L. Y., Yeh, S. L., Hsu, S. T., Huang, S. M., Chau, C. F., & Chuang, C. H. (2026). Erinacine C Attenuates Alzheimer’s-like Pathology: A Study in APP/PS1 Mice and PC12 Cells. Molecules. https://doi.org/10.3390/molecules31183154

Vancouver

Wang LY, Yeh SL, Hsu ST, Huang SM, Chau CF, Chuang CH. Erinacine C Attenuates Alzheimer’s-like Pathology: A Study in APP/PS1 Mice and PC12 Cells. Molecules. 2026. doi:10.3390/molecules31183154

BibTeX
@article{Wang2026,
  author = {Wang, Li-Yu and Yeh, Shu-Lan and Hsu, Shih-Tien and Huang, Shu-Ming and Chau, Chi-Fai and Chuang, Cheng-Hung},
  title = {Erinacine C Attenuates Alzheimer’s-like Pathology: A Study in APP/PS1 Mice and PC12 Cells},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31183154}
}
Kostenlos starten →